Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy. Bone Marrow Transplant 2016 Sep;51(9):1241-4
Date
04/12/2016Pubmed ID
27064689DOI
10.1038/bmt.2016.87Scopus ID
2-s2.0-84963621743 (requires institutional sign-in at Scopus site) 51 CitationsAuthor List
Vasu S, Wu H, Satoskar A, Puto M, Roddy J, Blum W, Klisovic R, Andritsos L, Hofmeister C, Benson DM, Efebera Y, Jaglowski S, Penza S, Cohen D, Devine S, Cataland SAuthor
Samantha M. Jaglowski MD, MPH Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultAntibodies, Monoclonal, Humanized
Complement Activation
Complement C5
Female
Hematopoietic Stem Cell Transplantation
Humans
Male
Middle Aged
Thrombotic Microangiopathies
Transplantation, Homologous
Young Adult